InTech uses cookies to offer you the best online experience. By continuing to use our site, you agree to our Privacy Policy.

Biochemistry, Genetics and Molecular Biology » "Modern Tools for Genetic Engineering", book edited by Michael S.D. Kormann, ISBN 978-953-51-2234-0, Print ISBN 978-953-51-2392-7, Published: May 18, 2016 under CC BY 3.0 license. © The Author(s).

Chapter 6

Insulin Gene Therapy for Type 1 Diabetes Mellitus: Unique Challenges Require Innovative Solutions

By Andrew M Handorf, Hans W Sollinger and Tausif Alam
DOI: 10.5772/62657

  1. Vehik K, Ajami NJ, Hadley D, Petrosino JF, Burkhardt BR. The changing landscape of type 1 diabetes: recent developments and future frontiers. Current Diabetes Reports. 2013;13(5):642–50. PubMed PMID: 23912764. Pubmed Central PMCID: 3827778.

  2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine. 1993;329(14):977–86. PubMed PMID: 8366922.

  3. Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nature Reviews Endocrinology. 2011;7(7):385–95. PubMed PMID: 21343892.

  4. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ. 2011;342:d1855. PubMed PMID: 21493665. Pubmed Central PMCID: 3077739.

  5. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of pancreas and duodenum along with kidney in diabetic nephropathy. Surgery. 1967;61(6):827. PubMed PMID: WOS:A19679431400001.

  6. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes. 2002;51(12):3428–34. PubMed PMID: 12453896.

  7. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. The New England Journal of Medicine. 2000;343(4):230–8. PubMed PMID: 10911004.

  8. Tian CR, Bagley J, Cretin N, Seth N, Wucherpfennig KW, Iacomini J. Prevention of type 1 diabetes by gene therapy. Journal of Clinical Investigation. 2004;114(7):969–78. PubMed PMID: WOS:000224223800018.

  9. Piccirillo CA, Chang Y, Prud'homme GJ. TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. Journal of Immunology. 1998;161(8):3950–6. PubMed PMID: 9780163.

  10. Khachatryan A, Guerder S, Palluault F, Cote G, Solimena M, Valentijn K, et al. Targeted expression of the neuropeptide calcitonin gene-related peptide to beta cells prevents diabetes in NOD mice. Journal of Immunology. 1997;158(3):1409–16. PubMed PMID: 9013986.

  11. Liu Y, Rabinovitch A, Suarez-Pinzon W, Muhkerjee B, Brownlee M, Edelstein D, et al. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis. Human Gene Therapy. 1996;7(14):1719–26. PubMed PMID: 8886842.

  12. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. The New England Journal of Medicine. 1994;331(21):1428–36. PubMed PMID: 7969282.

  13. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008;455(7213):627–32. PubMed PMID: 18754011.

  14. Li W, Nakanishi M, Zumsteg A, Shear M, Wright C, Melton DA, et al. In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. eLife. 2014;3:e01846. PubMed PMID: 24714494. Pubmed Central PMCID: 3977343.

  15. Mauda-Havakuk M, Litichever N, Chernichovski E, Nakar O, Winkler E, Mazkereth R, et al. Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate. PLoS One. 2011;6(10):e26298. PubMed PMID: 22028850. Pubmed Central PMCID: 3196540.

  16. Li H, Li X, Lam KS, Tam S, Xiao W, Xu R. Adeno-associated virus-mediated pancreatic and duodenal homeobox gene-1 expression enhanced differentiation of hepatic oval stem cells to insulin-producing cells in diabetic rats. Journal of Biomedical Science. 2008;15(4):487–97. PubMed PMID: 18253862.

  17. Lin G, Wang G, Liu G, Yang LJ, Chang LJ, Lue TF, et al. Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem cells and development. 2009;18(10):1399–406. PubMed PMID: 19245309. Pubmed Central PMCID: 2862049.

  18. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nature Medicine. 2000;6(5):568–72. PubMed PMID: 10802714.

  19. Noguchi H, Xu G, Matsumoto S, Kaneto H, Kobayashi N, Bonner-Weir S, et al. Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell Transplant. 2006;15(10):929–38. PubMed PMID: WOS:000243780000012. English.

  20. Yatoh S, Akashi T, Chan PP, Kaneto H, Sharma A, Bonner-Weir S, et al. NeuroD and reaggregation induce beta-cell specific gene expression in cultured hepatocytes. Diabetes/Metabolism Research and Reviews. 2007;23(3):239–49. PubMed PMID: 16921545.

  21. Wang AY, Ehrhardt A, Xu H, Kay MA. Adenovirus transduction is required for the correction of diabetes using Pdx-1 or neurogenin-3 in the liver. Molecular Therapy. 2007;15(2):255–63. PubMed PMID: WOS:000244405200007.

  22. Kaneto H, Nakatani Y, Miyatsuka T, Matsuoka T, Matsuhisa M, Hori M, et al. PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes. 2005;54(4):1009–22. PubMed PMID: WOS:000228094300012.

  23. Song YD, Lee EJ, Yashar P, Pfaff LE, Kim SY, Jameson JL. Islet cell differentiation in liver by combinatorial expression of transcription factors Neurogenin-3, BETA2, and RIPE3b1. Biochemical and Biophysical Research Communications. 2007;354(2):334–9. PubMed PMID: WOS:000244050000002.

  24. Heremans Y, Van De Casteele M, Veld PI, Gradwohl G, Serup P, Madsen O, et al. Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol. 2002;159(2):303–11. PubMed PMID: WOS:000179051500011.

  25. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008;455(7213):627–30. PubMed PMID: WOS:000259639700038.

  26. Gefen-Halevi S, Rachmut IH, Molakandov K, Berneman D, Mor E, Meivar-Levy I, et al. NKX6.1 promotes PDX-1-induced liver to pancreatic beta-cells reprogramming. Cellular Reprogramming. 2010;12(6):655–64. PubMed PMID: 21108535.

  27. Shternhall-Ron K, Quintana FJ, Perl S, Meivar-Levy I, Barshack I, Cohen IR, et al. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. Journal of Autoimmunity. 2007;28(2–3):134–42. PubMed PMID: 17383157.

  28. Roep BO, Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harbor Perspectives in Medicine. 2012;2(4):a007781. PubMed PMID: 22474615. Pubmed Central PMCID: 3312399.

  29. Newgard CB, McGarry JD. Metabolic coupling factors in pancreatic beta-cell signal transduction. Annual Review of Biochemistry. 1995;64:689–719. PubMed PMID: 7574498.

  30. Ishihara H, Wang H, Drewes LR, Wollheim CB. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. The Journal of Clinical Investigation. 1999;104(11):1621–9. PubMed PMID: 10587526. Pubmed Central PMCID: 409861.

  31. Melloul D, Marshak S, Cerasi E. Regulation of insulin gene transcription. Diabetologia. 2002;45(3):309–26. PubMed PMID: 11914736.

  32. Zhao L, Guo M, Matsuoka TA, Hagman DK, Parazzoli SD, Poitout V, et al. The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription. The Journal of Biological Chemistry. 2005;280(12):11887–94. PubMed PMID: 15665000.

  33. Tillmar L, Welsh N. Glucose-induced binding of the polypyrimidine tract-binding protein (PTB) to the 3′-untranslated region of the insulin mRNA (ins-PRS) is inhibited by rapamycin. Molecular and Cellular Biochemistry. 2004;260(1–2):85–90. PubMed PMID: WOS:000221121000011.

  34. Wicksteed B, Herbert TP, Alarcon C, Lingohr MK, Moss LG, Rhodes CJ. Cooperativity between the preproinsulin mRNA untranslated regions is necessary for glucose-stimulated translation. Journal of Biological Chemistry. 2001;276(25):22553–8. PubMed PMID: WOS:000169412700078.

  35. Welsh M, Nielsen DA, MacKrell AJ, Steiner DF. Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability. The Journal of Biological Chemistry. 1985;260(25):13590–4. PubMed PMID: 3902821.

  36. Tillmar L, Welsh N. Hypoxia may increase rat insulin mRNA levels by promoting binding of the polypyrimidine tract-binding protein (PTB) to the pyrimidine-rich insulin mRNA 3′-untranslated region. Mol Med. 2002;8(5):263–72. PubMed PMID: WOS:000178018100005.

  37. Hutton JC. Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases. Diabetologia. 1994;37:S48–56. PubMed PMID: WOS:A1994PE89100008. English.

  38. Steiner DF. The proprotein convertases. Current Opinion in Chemical Biology. 1998;2(1):31–9. PubMed PMID: WOS:000072701000005.

  39. McIntosh CHS, Widenmaier S, Kim SJ. Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; Gip). Vitamins & Hormones. 2009;80:409–71. PubMed PMID: WOS:000264638200015.

  40. Nolan CJ, Prentki M. The islet beta-cell: fuel responsive and vulnerable. Trends in Endocrinology & Metabolism. 2008;19(8):285–91. PubMed PMID: WOS:000260444900003.

  41. Pongratz RL, Kibbey RG, Shulman GI, Cline GW. Cytosolic and mitochondrial malic enzyme isoforms differentially control insulin secretion. The Journal of Biological Chemistry. 2007;282(1):200–7. PubMed PMID: 17102138.

  42. Revers RR, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, et al. The effects of biosynthetic human proinsulin on carbohydrate-metabolism. Diabetes. 1984;33(8):762–70. PubMed PMID: WOS:A1984TB55400010.

  43. Peters RT, Low SC, Kamphaus GD, Dumont JA, Amari JV, Lu Q, et al. Prolonged activity of factor IX as a monomeric Fc fusion protein. Blood. 2010;115(10):2057–64. PubMed PMID: 20056791.

  44. Callejas D, Mann CJ, Ayuso E, Lage R, Grifoll I, Roca C, et al. Treatment of diabetes and long-term survival after insulin and glucokinase gene therapy. Diabetes. 2013;62(5):1718–29. PubMed PMID: 23378612. Pubmed Central PMCID: 3636629.

  45. Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, et al. Glucose-dependent insulin release from genetically engineered K cells. Science. 2000;290(5498):1959–62. PubMed PMID: WOS:000165810000044.

  46. Nakayama M. Insulin as a key autoantigen in the development of type 1 diabetes. Diabetes/Metabolism Research. 2011;27(8):773–7. PubMed PMID: WOS:000300108000009.

  47. Ramshur EB, Rull TR, Wice BM. Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo. Journal of Cellular Physiology. 2002;192(3):339–50. PubMed PMID: 12124779.

  48. Chen RH, Meseck ML, Woo SLC. Auto-regulated hepatic insulin gene expression in type 1 diabetic rats. Molecular Therapy. 2001;3(4):584–90. PubMed PMID: WOS:000168367500023.

  49. Chen R, Meseck M, McEvoy RC, Woo SL. Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells. Gene Therapy. 2000;7(21):1802–9. PubMed PMID: 11110411.

  50. Burkhardt BR, Parker MJ, Zhang YC, Song SH, Wasserfall CH, Atkinson MA. Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice. FEBS Letters. 2005;579(25):5759–64. PubMed PMID: WOS:000232824200053.

  51. Hsu PYJ, Kotin RM, Yang YW. Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes. Pharmaceutical Research. 2008;25(6):1460–8. PubMed PMID: WOS:000255753900022.

  52. Towle HC. Glucose as a regulator of eukaryotic gene transcription. Trends in Endocrinology & Metabolism. 2005;16(10):489–94. PubMed PMID: WOS:000234024200006.

  53. Atchley WR, Fitch WM. A natural classification of the basic helix-loop-helix class of transcription factors. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(10):5172–6. PubMed PMID: 9144210. Pubmed Central PMCID: 24651.

  54. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(19):7281–6. PubMed PMID: 15118080. Pubmed Central PMCID: 409910.

  55. Thule PM, Liu J, Phillips LS. Glucose regulated production of human insulin in rat hepatocytes. Gene Therapy. 2000;7(3):205–14. PubMed PMID: 10694797.

  56. Thule PM, Liu JM. Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Therapy. 2000;7(20):1744–52. PubMed PMID: 11083496.

  57. Alam T, Sollinger HW. Glucose-regulated insulin production in hepatocytes. Transplantation. 2002;74(12):1781–7. PubMed PMID: 12499898.

  58. Kuwahata M, Kuramoto Y, Sawai Y, Amano S, Tomoe Y, Segawa H, et al. Polypyrimidine tract-binding protein is involved in regulation of albumin synthesis in response to food intake. Journal of Nutritional Science and Vitaminology. 2008;54(2):142–7. PubMed PMID: WOS:000255558500005.

  59. Groskreutz DJ, Sliwkowski MX, Gorman CM. Genetically-engineered proinsulin constitutively processed and secreted as mature, active insulin. Journal of Biological Chemistry. 1994;269(8):6241–5. PubMed PMID: WOS:A1994MY84000112.

  60. Yanagita M, Hoshino H, Nakayama K, Takeuchi T. Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell-lines. Endocrinology. 1993;133(2):639–44. PubMed PMID: WOS:A1993LQ84600031.

  61. Kaarsholm NC, Norris K, Jorgensen RJ, Mikkelsen J, Ludvigsen S, Olsen OH, et al. Engineering stability of the insulin monomer fold with application to structure-activity relationships. Biochemistry. 1993;32(40):10773–8. PubMed PMID: 8399225.

  62. Cantore A, Ranzani M, Bartholomae CC, Volpin M, Valle PD, Sanvito F, et al. Liver-directed lentiviral gene therapy in a dog model of hemophilia B. Science Translational Medicine. 2015;7(277):277ra28. PubMed PMID: 25739762.

  63. Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocrine Reviews. 1998;19(5):608–24. PubMed PMID: WOS:000076368400006.

  64. Alam T, Wai P, Held D, Vakili ST, Forsberg E, Sollinger H. Correction of diabetic hyperglycemia and amelioration of metabolic anomalies by minicircle DNA mediated glucose-dependent hepatic insulin production. PLoS One. 2013;8(6):e67515. PubMed PMID: 23826312. Pubmed Central PMCID: 3694888.

  65. Morgan RA, Anderson WF. Human gene-therapy. Annual Review of Biochemistry. 1993;62:191–217. PubMed PMID: WOS:A1993LK68700008.

  66. Volpers C, Kochanek S. Adenoviral vectors for gene transfer and therapy. Journal of Gene Medicine. 2004;6:S164–71. PubMed PMID: WOS:000220114400015.

  67. Short DK, Okada S, Yamauchi K, Pessin JE. Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. American Journal of Physiology – Endocrinology and Metabolism. 1998;275(5):E748–56. PubMed PMID: WOS:000076913700004.

  68. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(24):13565–70. PubMed PMID: 8942974. Pubmed Central PMCID: 19345.

  69. Parks RJ, Graham FL. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. Journal of Virology. 1997;71(4):3293–8. PubMed PMID: 9060698. Pubmed Central PMCID: 191467.

  70. Marshall E. Clinical trials—Gene therapy death prompts review of adenovirus vector. Science. 1999;286(5448):2244–5. PubMed PMID: WOS:000084318500002.

  71. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee. Human Gene Therapy. 2002;13(1):3–13. PubMed PMID: WOS:000173075000002.

  72. Hausl MA, Zhang W, Muther N, Rauschhuber C, Franck HG, Merricks EP, et al. Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B. Molecular Therapy: The Journal of the American Society of Gene Therapy. 2010;18(11):1896–906. PubMed PMID: 20717103. Pubmed Central PMCID: 2990515.

  73. Muzyczka N. Use of adenoassociated virus as a general transduction vector for mammalian-cells. Current Topics in Microbiology. 1992;158:97–129. PubMed PMID: WOS:A1992JB19700006.

  74. Park YM, Woo SA, Lee GT, Ko JY, Lee Y, Zhao ZS, et al. Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague–Dawley rats. Journal of Gene Medicine. 2005;7(5):621–9. PubMed PMID: WOS:000229297100010.

  75. Muzzin P, Eisensmith RC, Copeland KC, Woo SLC. Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Molecular Endocrinology. 1997;11(6):833–7. PubMed PMID: WOS:A1997XA52800020.

  76. Cavazzana-Calvo M, Hacein-Bey S, Basile CD, Gross F, Yvon E, Nusbaum P, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288(5466):669–72. PubMed PMID: WOS:000086727100043.

  77. Ronen K, Negre O, Roth S, Colomb C, Malani N, Denaro M, et al. Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat beta-thalassemia. Molecular Therapy. 2011;19(7):1273–86. PubMed PMID: WOS:000292295900014.

  78. Papayannakos C, Daniel R. Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy. Gene Therapy. 2013;20(6):581–8. PubMed PMID: WOS:000319976600001.

  79. Schweizer M, Merten OW. Large-scale production means for the manufacturing of lentiviral vectors. Current Gene Therapy. 2010;10(6):474–86. PubMed PMID: WOS:000285778400006.

  80. Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genetics. 1997;17(3):314–7. PubMed PMID: 9354796.

  81. Hwang BY, Schaffer DV. Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors. Gene Therapy. 2013;20(8):807–15. PubMed PMID: 23364315. Pubmed Central PMCID: 3735647.

  82. Ren B, O'Brien BA, Swan MA, Koina ME, Nassif N, Wei MQ, et al. Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia. 2007;50(9):1910–20. PubMed PMID: WOS:000248771800016.

  83. Ren BH, O'Brien BA, Byrne MR, Ch'ng E, Gatt PN, Swan MA, et al. Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy. Journal of Gene Medicine. 2013;15(1):28–41. PubMed PMID: WOS:000314178500005.